RedHill Biopharma RDHL Growth Metrics (2012-2023)

NASDAQ RDHL
$0.48 -0.02 (-4.79%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

RedHill Biopharma Quarterly Growth Metrics

Periods 45 quarters
Latest Jun 2023

RedHill Biopharma growth metrics data for the quarter ended Jun 2023. These growth metrics cover 45 quarters of results from Jun 2012 through Jun 2023, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023
Growth Ratios
EBITDA Margin Growth (1y)
-0.05M0.00M0.01M0.04M0.03M0.00M0.11M-0.07M-0.07M-0.07M-0.16M0.01M0.00M-0.07M0.00M-0.01M-0.00M0.01M-0.09M0.30M
EBITDA Margin Growth (3y)
-71.97M-0.27M-0.08M-0.06M-0.03M-0.03M-0.04M-0.14M-0.04M-0.08M-0.07M-0.13M-0.25M0.30M
EBITDA Margin Growth (5y)
9.18M-34.79M0.05M-10.22M-12.47M-48.14M-47.47M-58.97M-72.04M-0.28M-0.09M-0.13M-0.12M0.26M
EBITDA Margin (QoQ)
0.00M0.03M-0.02M0.03M-0.01M0.00M0.09M-0.16M948.000.00M-342.000.00M-0.00M-0.07M0.08M-0.01M-999.00-0.06M-0.02M0.38M
EBIT Margin Growth (1y)
-0.05M0.00M0.01M0.04M0.03M87.000.11M-0.07M-0.06M-0.06M-0.15M0.01M0.00M-0.07M0.00M-0.01M-0.00M0.00M-0.09M0.29M
EBIT Margin Growth (3y)
-71.86M-0.27M-0.08M-0.06M-0.03M-0.03M-0.04M-0.14M-0.04M-0.07M-0.07M-0.13M-0.24M0.29M
EBIT Margin Growth (5y)
9.21M-34.73M0.05M-10.21M-12.46M-48.07M-47.39M-58.89M-71.93M-0.28M-0.09M-0.13M-0.12M0.26M
EBIT Margin (QoQ)
0.00M0.03M-0.02M0.03M-0.01M0.00M0.09M-0.16M923.000.00M-361.000.00M-0.00M-0.07M0.08M-0.01M-943.00-0.06M-0.02M0.38M
EBT Margin Growth (1y)
-0.04M-291.000.01M0.05M0.03M-0.02M0.11M-0.08M-0.07M-0.07M-0.15M0.01M0.00M-0.07M0.00M-0.01M-0.02M0.01M-0.03M0.32M
EBT Margin Growth (3y)
-78.27M-0.33M-0.08M-0.08M-0.03M-0.02M-0.04M-0.16M-0.04M-0.09M-0.08M-0.13M-0.18M0.32M
EBT Margin Growth (5y)
9.02M-35.11M0.04M-9.17M-14.39M-39.75M-48.52M-51.84M-78.35M-0.33M-0.09M-0.15M-0.06M0.29M
EBT Margin (QoQ)
0.01M0.05M-0.04M0.04M-0.02M0.00M0.08M-0.15M626.000.00M-496.000.00M-0.00M-0.07M0.08M-0.01M-0.02M-0.04M0.03M0.35M
FCF Margin Growth (1y)
0.03M0.01M-0.00M-0.03M-0.03M-0.03M-0.05M0.06M0.06M0.08M0.09M-0.00M-0.00M-834.000.00M-162.000.01M0.00M-0.02M-0.05M
FCF Margin Growth (3y)
57.14M0.19M0.06M0.06M0.03M0.03M0.03M0.05M0.04M0.06M0.06M0.09M0.08M-0.05M
FCF Margin Growth (5y)
6.97M24.46M-0.05M10.33M9.44M58.92M33.60M46.74M57.20M0.19M0.07M0.07M0.02M-0.02M
FCF Margin (QoQ)
-0.00M-0.02M0.02M-0.02M0.00M-0.02M-0.01M0.09M0.00M-0.00M-22.00-0.00M-7.000.00M0.00M-0.01M0.01M0.00M-0.02M-0.04M
Gross Margin Growth (1y)
0.00M295.000.00M366.00-0.00M-659.00-0.01M-0.00M-446.00-7.000.01M0.00M665.00-0.00M181.0022.00-0.00M0.00M323.00415.00
Gross Margin Growth (3y)
-0.00M-0.00M0.00M-371.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-895.00-0.00M0.01M0.00M
Gross Margin Growth (5y)
-902.00-0.00M-0.00M-0.00M-0.00M728.00755.00-0.00M-675.00-0.00M
Gross Margin (QoQ)
374.00-0.00M0.00M-318.00-0.00M-466.00-0.01M0.01M0.00M-28.00-20.0058.00654.00-0.00M0.00M-101.00-482.00-0.00M0.00M-9.00
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
146.48%-79.35%-93.38%2,905.64%201.44%-72.44%436.40%-97.96%-94.40%-93.25%-92.03%71.22%26.75%-1,004.85%11.39%-62.88%-94.85%20.52%-1,723.72%1,184.06%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-19.07%0.40%-88.52%-17.67%63.02%35.80%-38.09%-87.91%-25.33%-84.34%-69.53%1.70%-40.17%-29.43%-21.92%-76.49%-84.59%-35.45%-50.97%101.33%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
15.12%-19.99%-59.53%85.70%35.26%46.36%11.76%-12.71%-38.28%-54.82%-76.98%-54.48%-21.00%-28.69%-53.80%-74.29%-51.38%-15.19%-20.22%38.05%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
264.41%1,025.31%-96.09%1,772.18%-63.45%2.89%-23.81%-92.87%0.19%23.88%-10.03%53.32%-25.83%-984.36%111.08%-48.91%-89.71%-13,750.42%-126.26%140.40%
Net Margin Growth (1y)
0.15M0.06M0.02M0.02M0.02M0.02M0.11M-0.06M-0.06M-0.06M-0.17M-0.02M-0.02M-0.02M0.03M0.01M-0.01M0.01M-0.16M0.57M
Net Margin Growth (3y)
65.59M0.24M0.11M0.01M-0.05M-0.06M-0.06M-0.07M-0.04M-0.08M-0.09M-0.08M-0.30M0.56M
Net Margin Growth (5y)
9.04M-34.34M0.05M11.38M10.66M-53.21M46.58M65.97M65.51M0.22M0.08M-0.00M-0.18M0.52M
Net Margin (QoQ)
-0.00M0.01M281.000.01M411.000.00M0.09M-0.15M0.00M0.00M-0.02M-0.00M0.00M-0.00M0.03M-0.02M-0.01M0.02M-0.14M0.70M
Operating Margin Growth (1y)
-0.05M0.00M0.01M0.04M0.03M87.000.11M-0.07M-0.06M-0.06M-0.15M0.01M0.00M-0.07M0.00M-0.01M-0.00M0.00M-0.09M0.29M
Operating Margin Growth (3y)
-71.86M-0.27M-0.08M-0.06M-0.03M-0.03M-0.04M-0.14M-0.04M-0.07M-0.07M-0.13M-0.24M0.29M
Operating Margin Growth (5y)
9.21M-34.73M0.05M-10.21M-12.46M-48.07M-47.39M-58.89M-71.93M-0.28M-0.09M-0.13M-0.12M0.26M
Operating Margin (QoQ)
0.00M0.03M-0.02M0.03M-0.01M0.00M0.09M-0.16M923.000.00M-361.000.00M-0.00M-0.07M0.08M-0.01M-943.00-0.06M-0.02M0.38M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.00M0.00M0.00M0.00M593.00-694.000.00M0.00M0.00M0.00M468.00-948.00-0.00M-957.00969.000.00M0.00M0.00M-0.01M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.00M-0.00M-0.00M-0.00M-0.01M-0.00M-461.00981.000.00M0.00M0.01M0.00M0.00M0.00M0.00M0.01M0.01M-0.00M0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.00M-849.00-0.00M-0.00M-667.00-759.00236.00-0.00M-932.00867.000.00M0.01M-275.000.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M0.00M275.00-719.00-0.00M0.00M0.00M0.00M-256.00-573.00272.00-391.00-529.00-309.000.00M916.00-947.000.00M-0.01M0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M-0.00M-0.00M-0.00M0.00M0.00M0.05M-0.01M0.01M-0.00M-0.04M0.00M0.02M-0.01M-0.47M-0.91M0.44M0.88M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.01M0.00M0.00M0.01M0.01M0.00M0.05M-0.00M0.01M-0.01M0.01M-0.01M0.03M-0.02M-0.46M-0.91M-0.07M-0.03M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.01M0.01M0.01M0.01M0.00M0.05M-0.00M0.02M0.00M0.02M0.00M0.03M-0.01M-0.46M-0.91M-0.03M-0.04M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.00M-0.01M480.000.00M0.00M-0.01M0.05M-0.05M0.02M-0.01M0.01M-0.01M0.03M-0.05M-0.44M-0.45M-0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.01M0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.03M-0.01M-0.01M-0.03M-0.06M-4.49M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.01M-0.01M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.03M-0.09M-4.50M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.03M-0.02M-0.02M-0.04M-0.09M-4.51M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.00M0.00M200.00-0.00M-0.00M0.00M643.00-0.00M-0.01M-0.02M0.01M0.00M-0.02M-0.05M-4.41M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.05M0.00M0.01M0.04M0.03M87.000.11M-0.07M-0.06M-0.06M-0.15M0.01M0.00M-0.07M0.00M-0.01M-0.00M0.00M-0.09M0.29M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-71.86M-0.27M-0.08M-0.06M-0.03M-0.03M-0.04M-0.14M-0.04M-0.07M-0.07M-0.13M-0.24M0.29M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
9.21M-34.73M0.05M-10.21M-12.46M-48.07M-47.39M-58.89M-71.93M-0.28M-0.09M-0.13M-0.12M0.26M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.00M0.03M-0.02M0.03M-0.01M0.00M0.09M-0.16M923.000.00M-361.000.00M-0.00M-0.07M0.08M-0.01M-943.00-0.06M-0.02M0.38M

RedHill Biopharma Growth Metrics API

Pull RedHill Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RDHL&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY